Events Search and Views Navigation
November 2019
5th Resvinet Conference RSVVW 2019
Organized by the Respiratory Syncytial Virus Network (ReSViNET) Foundation, the “RSVVW 2019” A Global Conference on Novel RSV Preventive and Therapeutic Interventions, will be held on November 12th-14th, 2019 in Accra, Ghana.
Find out more »March 2020
10th Annual Vaccine World Summit
Vaccination programs save millions of lives each year globally. With more than 100 million children immunized each year, global immunization coverage has never been higher. Sources indicate that the worldwide market for vaccines is expected to reach USD 48.03 Billion by 2021 from USD 32.24 Billion in 2016 at a CAGR of 8.3% from 2016 to 2021. The key drivers driving the growth of this market are a high prevalence of diseases, rising government and nongovernment funding for vaccine development,…
Find out more »May 2020
ASGCT 23rd Annual Meeting
The ASGCT 23rd Annual Meeting will be the world’s largest gathering of gene and cell therapy researchers and provides an international forum where the latest scientific developments are presented and critically discussed.
Viroclinics team members will showcase clinical diagnostic services to detect AAVs in clinical samples.
September 2020
World Vaccine Congress Washington 2020
The 20th Annual World Vaccine Congress is the place where the global vaccine industry meets to discuss commercial and scientific issues around regulation, strategy, manufacturing, trials, partnering, influenza, cancer and emerging diseases. The conference tackles the latest issues affecting vaccines for respiratory diseases including influenza, TB, RSV and MERS to stimulate the industry to develop more effective vaccines. We will present our views on how R&D outsourcing can stimulate the innovation processes for vaccine developers. Practical case examples will be…
Find out more »October 2020
Webinar: Towards a polio free world, the importance and GAP III requisites of (pre)clinical analyses models
This webinar looks at the challenges surrounding (pre)clinical diagnostics and highlights the main GAP III regulatory directives and policies applicable to a polio essential facility. We invite you to join us for a webinar (hosted by the Developing Countries Vaccine Manufacturers Network and Viroclinics-DDL) to learn from our experts about their experiences, operational insights and best practices. Our goal is to ultimately contribute to a polio free world.
Find out more »
